• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.

作者信息

McLeod H L, Miller D R, Evans W E

出版信息

Lancet. 1993 May 1;341(8853):1151. doi: 10.1016/0140-6736(93)93168-z.

DOI:10.1016/0140-6736(93)93168-z
PMID:8097831
Abstract
摘要

相似文献

1
Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.硫嘌呤甲基转移酶缺乏的心脏移植受者中硫唑嘌呤诱导的骨髓抑制。
Lancet. 1993 May 1;341(8853):1151. doi: 10.1016/0140-6736(93)93168-z.
2
Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.
Lancet. 1993 Feb 13;341(8842):436. doi: 10.1016/0140-6736(93)93028-y.
3
Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C).硫嘌呤甲基转移酶缺陷基因型（TPMT*3A/*3C）的肾移植患者发生严重的硫唑嘌呤诱导的骨髓毒性。
Transpl Int. 2005 May;18(5):623-5. doi: 10.1111/j.1432-2277.2005.00095.x.
4
Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis.一名自身免疫性肝炎患者因硫嘌呤甲基转移酶缺乏导致硫唑嘌呤引起的骨髓抑制。
J Hepatol. 1995 Sep;23(3):351-4. doi: 10.1016/0168-8278(95)80481-1.
5
Azathioprine-induced pancytopenia in homozygous thiopurine methyltransferase-deficient renal transplant recipients: a family study.纯合子硫嘌呤甲基转移酶缺陷型肾移植受者中硫唑嘌呤诱导的全血细胞减少症：一项家族研究
Transplant Proc. 1995 Apr;27(2):1739-42.
6
Two cases of thiopurine methyltransferase (TPMT) deficiency--a lucky save and a near miss with azathioprine.两例硫嘌呤甲基转移酶（TPMT）缺乏症——使用硫唑嘌呤时一次幸运的挽救和一次险些酿成的大祸。
Br J Clin Pharmacol. 2006 Oct;62(4):473-6. doi: 10.1111/j.1365-2125.2005.02474.x.
7
[Homozygote deficiency of thiopurine methyltransferase. A contraindication to the use of azathioprine in kidney transplantation].[硫嘌呤甲基转移酶纯合子缺乏症。肾移植中使用硫唑嘌呤的禁忌证]
Presse Med. 1995 Sep 23;24(27):1257-9.
8
Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase.硫唑嘌呤诱发的脓疱病患者全血细胞减少及红细胞硫嘌呤甲基转移酶缺乏
BMJ. 2005 Feb 12;330(7487):350-1. doi: 10.1136/bmj.330.7487.350.
9
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.炎症性肠病中硫唑嘌呤和6-巯基嘌呤的药物遗传学及代谢物监测
J Gastroenterol Hepatol. 2005 Aug;20(8):1149-57. doi: 10.1111/j.1440-1746.2005.03832.x.
10
Fatal myelotoxicity after azathioprine treatment.硫唑嘌呤治疗后发生的致命性骨髓毒性。
Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):661-5. doi: 10.1080/15257770802143905.

引用本文的文献

1
Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.硫嘌呤甲基转移酶基因多态性对埃及急性淋巴细胞白血病患儿的影响。
J Genet. 2017 Dec;96(6):905-910. doi: 10.1007/s12041-017-0853-0.
2
The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.遗传性NUDT15基因多态性对日本急性淋巴细胞白血病儿童硫嘌呤活性代谢物的影响。
Pharmacogenet Genomics. 2017 Jun;27(6):236-239. doi: 10.1097/FPC.0000000000000282.
3
Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population.
利比亚人群中硫嘌呤甲基转移酶基因的多态性
Libyan J Med. 2015 Mar 26;10(1):27053. doi: 10.3402/ljm.v10.27053. eCollection 2015.
4
Assessment of Thiopurine-based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia.根据硫嘌呤甲基转移酶基因型对急性淋巴细胞白血病患者使用硫嘌呤类药物的评估。
Iran J Ped Hematol Oncol. 2014;4(1):32-8. Epub 2014 Apr 20.
5
Cancer pharmacogenomics in children: research initiatives and progress to date.儿童癌症药物基因组学：研究计划和迄今为止的进展。
Paediatr Drugs. 2013 Apr;15(2):71-81. doi: 10.1007/s40272-013-0021-9.
6
Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.第三部分：II 期抗癌药物代谢中的药物遗传学变异性。
Oncologist. 2011;16(7):992-1005. doi: 10.1634/theoncologist.2010-0260. Epub 2011 Jun 9.
7
Major remodelling of the murine stem cell kinome following differentiation in the hematopoietic compartment.造血谱系分化后，鼠类干细胞激酶组发生重大重构。
J Proteome Res. 2011 Aug 5;10(8):3542-50. doi: 10.1021/pr2001594. Epub 2011 Jun 28.
8
LC-MS/MS coupled with stable isotope dilution method for the quantification of 6-thioguanine and S(6)-methylthioguanine in genomic DNA of human cancer cells treated with 6-thioguanine.LC-MS/MS 结合稳定同位素稀释法测定经 6-硫代鸟嘌呤处理的人癌细胞基因组 DNA 中 6-硫代鸟嘌呤和 S(6)-甲基硫代鸟嘌呤的含量。
Anal Chem. 2010 Jul 1;82(13):5797-803. doi: 10.1021/ac1008628.
9
Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.抗癌和免疫抑制硫唑嘌呤类药物巯嘌呤和硫唑嘌呤的药物基因组学研究。
Br J Clin Pharmacol. 2008 Oct;66(4):517-28. doi: 10.1111/j.1365-2125.2008.03248.x. Epub 2008 Jun 28.
10
Clinical pharmacology and pharmacogenetics of thiopurines.硫唑嘌呤的临床药理学与药物遗传学
Eur J Clin Pharmacol. 2008 Aug;64(8):753-67. doi: 10.1007/s00228-008-0478-6. Epub 2008 May 28.